Medicare Sets Coverage Rules for Alzheimer's Drugs
The Centers for Medicare & Medicaid Services (CMS) says it will cover expensive new Alzheimer’s disease drugs that receive full approval from the U.S. Food and Drug Administration (FDA). This is the agency’s normal policy with new medications, but its Alzheimer’s announcement carries an important twist: creation of a registry system that prescribing doc…
Keep reading with a 7-day free trial
Subscribe to Aging in America to keep reading this post and get 7 days of free access to the full post archives.